Introduction to the Conference
Chairman's Introduction
Self-sufficiency — 20 years on
Can the supply and demand for plasma-derived products ever be reconciled? Self-sufficiency from the viewpoint of a blood transfusion service
Can the supply and demand for plasma-derived products ever be reconciled?
Discussion I
Is the unpaid/paid donation debate for better or for worse? — advantages of unpaid donations
Is the unpaid/paid donation debate for better or for worse? — a commercial viewpoint
Discussion II
Is self-sufficiency financially viable and ethically justifiable?—the role of the National Blood Authority
Is self-sufficiency financially viable and ethically justifiable?—legal aspects
Is self-sufficiency financially viable and ethically justifiable?—a commercial viewpoint
Discussion III
Should clinical freedom be constrained in the name of self-sufficiency?
Economic issues in European self-sufficiency
European regulatory issues
Discussion IV
Do safety issues of plasma products constrain self-sufficiency?
Is haemophilia prophylaxis achievable in the context of self-sufficiency?
How will immune tolerance protocols affect self-sufficiency goals?
Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies
Discussion V
Accord
A comparison of the European Accord and the Recommendations of the American National Hemophilia Foundation
Registered Participants
Author Index
Key Word Index